国际麻醉学与复苏杂志   2019, Issue (3): 0-0
    
右美托咪定预处理通过抑制钙超载减轻H9C2细胞氧糖剥夺/复氧损伤
袁梅, 孟晓文, 宋绍永, 彭科, 嵇富海1()
1.苏州大学附属第一医院
Dexmedetomidine preconditioning protects H9C2 cells against oxygen glucose deprivation/reoxygenation injury through mitigating calcium overload
 全文:
摘要:

目的 探究右美托咪定(dexmedetomidine, Dex)预处理对H9C2细胞氧糖剥夺/复氧(oxygen glucose deprivation/reoxygenation, OGD/R)损伤模型中钙离子的影响。 方法 高糖培养至对数生长期的H9C2细胞采用随机数字表法分为5组(每组6个复孔):对照组(C组),常规培养细胞;OGD/R组,采用缺氧小室对细胞进行氧糖剥夺24 h处理,随后复氧3 h;不同浓度Dex预处理组(D1组、D2组、D3组),细胞氧糖剥夺前经不同浓度Dex(0.1、1.0、10.0 μmol/L) 预处理1 h,其余处理同OGD/R组。各组复氧结束后,倒置显微镜下观察细胞形态,应用甲基噻唑蓝[3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide, MTT]法检测各组细胞活力差异,应用2,4-二硝基苯肼显色法检测培养基乳酸脱氢酶(lactate dehydrogenase, LDH)释放率,应用钙成像方法检测细胞内钙离子浓度水平,应用实时定量聚合酶链反应(real-time quantitative polymerase chain reaction, RT?-q-PCR)检测FK506结合蛋白12.6(FK506-binding protein 12.6, FKBP12.6)mRNA表达情况。 结果 与C组比较,OGD/R组、D1组、D2组及D3组细胞活力明显降低(P<0.05),LDH释放率及细胞内钙离子浓度明显升高(P<0.05),OGD/R组和D2组FKBP12.6 mRNA表达量明显降低(P<0.05)。与OGD/R组比较,D2组、D3组细胞活力明显提高(P<0.05),细胞内钙离子浓度明显降低(P<0.05),D2组LDH释放率明显降低(P<0.05),FKBP12.6 mRNA表达量明显升高(P<0.05)。 结论 Dex预处理可以减轻H9C2细胞OGD/R损伤,其机制可能与增加钙调控相关分子FKBP12.6的表达从而抑制钙超载有关。

关键词: 右美托咪定; H9C2细胞; 氧糖剥夺/复氧; 钙超载
Abstract:

To investigate the protective effect of dexmedetomidine (Dex) preconditioning against oxygen glucose deprivation/reoxygenation (OGD/R) injury in H9C2 cells and its regulation on intracellular calcium. Methods Rat cardiomyocyte cell line H9C2 cells were cultured until reached logarithmic growth phase. Cultured H9C2 cells were equally and randomly divided into five groups (n=6). Normal control group (group C), in which the cells were cultured as usual. Group OGD/R, in which the medium was replaced with the Dulbecco′s modified Eagle medium(without glucose, bubbled with 5% CO2 and 95% N2 for 30 min). An anoxia chamber was used to establish OGD/R injury. Cells were cultured in the anoxia chamber 24 h with 5% CO2 and 95% N2 to produce oxygen glucose deprivation and then followed by 3 h reoxygenation(returned to the aerobic environment) 3 h. Dex preconditioning groups (group D1, D2 and D3 with 0.1, 1.0 μmol/L and 10.0 μmol/L Dex respectively), Dex was performed before the process of OGD/R. After reoxygenation, the morphology of cells were observed with inverted microscope. The difference of cell viability was examined by 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-H-tetrazolium bromide(MTT) method, while the lactate dehydrogenase (LDH) release were detected by 2, 4-dinitrophenylhydrazine chromogenic method. The calcium imaging technology was used to detect intracellular calcium concentration. The mRNA level of FK506-binding protein 12.6 (FKBP12.6) was detected by the real-time quantitative polymerase chain reaction (RT-q-PCR). Results Compared with group C, the viability were of cells was markedly decreased, the LDH release and intracellular calcium concentration of cells were significantly increased in groups of OGD/R, D1, D2 and D3 (P<0.05), the mRNA level of FKBP12.6 was decreased in group OGD/R and group D2(P<0.05). Compared with group OGD/R, the cell viability was increased and the intracellular calcium concentration was decreased in group D2 and group D3(P<0.05), the LDH release was decreased and the mRNA level of FKBP12.6 was increased in group D2 (P<0.05). Conclusions  Dex preconditioning protects H9C2 cells against OGD/R injury, which may be associated with an inhibition of the intracellular calcium overload by up-regulation of FKBP12.6.

Key words: Dexmedetomidine; H9C2 cell; Oxygen glucose deprivation/reoxygenation; Calcium overload